12:00 AM
Aug 14, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Angiogenic gene therapy regulatory update

The University of California (Oakland, Calif.) received U.S. Patent No. 6,100,242 covering the administration of angiogenic...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >